Latest News about Biotech and Pharmaceuticals
Recent news which mentions Biotech and Pharmaceuticals
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
February 21, 2025
From CNBC.com News
From CNBC.com News
UnitedHealth's rough stretch continues, with buyouts, a reported DOJ probe and a 23% drop in three months
February 21, 2025
From CNBC.com News
Eli Lilly aims to invest in 'big problems hiding in plain sight' using obesity windfall
February 20, 2025
From CNBC.com News
From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs
February 20, 2025
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
February 19, 2025
From CNBC.com News
UnitedHealthcare is offering buyouts to employees in benefits unit, could pursue layoffs, sources say
February 19, 2025
From CNBC.com News
Moderna beats on revenue but loses more than expected as it scales down manufacturing
February 14, 2025
From CNBC.com News
CVS shares are up 45% this year — here's why it may be starting to turn its business around
February 13, 2025
From CNBC.com News
U.S. investors, Big Pharma race to find new medicines in China
February 13, 2025
From CNBC.com News
Healthy Returns: What to know about Trump's NIH funding cuts
February 12, 2025
From CNBC.com News
CVS CEO defends pharmacy middlemen, accuses drugmakers of 'monopolistic' practices
February 12, 2025
From CNBC.com News
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
February 12, 2025
From CNBC.com News
From CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
February 10, 2025
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|